
    
      This study is intended to evaluate the safety and preliminary effectiveness of the RFMesh BAS
      for electrophysiological mapping and radiofrequency ablation in the region of the ostium of a
      targeted pulmonary vein in the treatment of drug refractory paroxysmal atrial fibrillation.
    
  